Acta Med. 2010, 53: 221-224
https://doi.org/10.14712/18059694.2016.80
Effects of Early Therapeutic Administration of Interleukin-1β on Survival Rate and Bone Marrow Hemopoiesis of Irradiated Mice
References
1. NV, Grebenyuk AN, Ketlinsky CA, Simbirtcev AS, Sidorov DA, Timoshevsky AA. Radioprotective effect of recombinant IL-1β on hematopoietic early precursors. Med Immunol 2003; 5(5–6): 621–5.
2. CA. The biological properties of interleukin-1. Eur Cytokine Netw 1994; 5(3): 517–31.
3. AN. Prospects of the use of recombinant cytokines in radiobiology and toxicology. Cytokines and Inflammation 2002; 1(2): 86–7.
4. AN, Sarkisyan KG, Timoshevsky AA. Antiradiation properties of interleukin- 1. Vestnik of Russian Medical Military Academy 2005; 1(13): 44–53.
5. NY, Orlovskaya IA, Dubinina LV. Participation of hematopoietic stem cells in the mechanisms of immunostimulating effect of interleukin-1 in mice. Immunol 1995; 2: 29–33.
6. SA, Simbirtsev AS. Cytokines. St. Petersburg: Foliant, 2008: 552.
7. VG, Moroz BB, Deshevoi YuB. Study of interleukin-1β radioprotective mechanisms on the model of bone marrow long-term cultures. Rad Biol Radioecol 2002; 42(1): 60–4.
8. R. Modulation of radiation damage by cytokines. Stem Cells 1997; 15 (suppl. 2): 87–94.
<https://doi.org/10.1002/stem.5530150713>
9. LM. Interleukin-1 – a central proinflammatory cytokine of pleiotropic action from the angle of treatment of radiation damages in the experiment and clinic. Med Radiol and Rad Safety 2001; 46(4): 5–11.
10. JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Rad Res 1961; 14(2): 213–22.
<https://doi.org/10.2307/3570892>
11. JK, MacViltie TJ, Blekely WF et al. Medical management of the acute radiation syndrome: Recommendations of the strategic national stockpile radiation working group. Ann Internal Med 2005; 140: 1037–51.
<https://doi.org/10.7326/0003-4819-140-12-200406150-00015>
